Defining the relative contribution of K27 methylation and S31 phosphorylation to gliomagenesis in dipg

Ended Project Grant Awarded Last action

Award ID
W81XWH2211045
Recipient
Awarding agency
Obligated
$556,454

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Place of performance
Minneapolis, MN 55455, USA

Award details come from USAspending.gov.

About this award

The University of Minnesota was awarded a three-year, $556,454 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research to define the relative contributions of K27 methylation and S31 phosphorylation to gliomagenesis in diffuse intrinsic pontine glioma (DIPG). Through September 2022 to August 2025, University researchers will investigate medical solutions for brain tumors on the battlefield by exploring epigenetic modifications involved in the development of DIPG, aiming to transform healthcare for service members and the public. The place of performance is Minneapolis, Minnesota.

Transactions

Action Obligated Date
Amendment $0
Original award $556,454

Quick answers

Who received award W81XWH2211045?

W81XWH2211045 was awarded to Regents Of The University Of Minnesota by Medical Command (Department of the Army) on September 1, 2022.

How much is award W81XWH2211045 worth?

$556,454 has been obligated on W81XWH2211045.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award